The Multidisciplinary Association for Psychedelic Studies (MAPS) is honored to announce the election of Carl L. Hart, Ph.D., to MAPS’ Board of Directors, effective as of October 22, 2021. Dr. Carl Hart, …
The psychedelic research renaissance, initially funded only by philanthropy and government grants, is generating increasingly promising data about therapeutic applications, and new understandings of the …
After 31 years since MAPS first tried to start research into MDMA-assisted therapy for PTSD inside the Veterans Affairs (VA) system, the first study participant has been enrolled in an investigator-initiated …
On October 4, 2021, Dr. Anne Wagner and a team of researchers at Remedy Institute in Toronto, Ontario, Canada, began studying MDMA-assisted cognitive processing therapy (CPT) for individuals with posttraumatic …
Dr. Benjamin Kelmendi and a team of researchers at Yale University in New Haven, Connecticut, are studying the effects of MDMA on prefrontal and amygdala activation in individuals with posttraumatic stress …
Dr. Leanne Williams and a team of researchers at Stanford University in Stanford, California, are using fMRI to studyhow MDMA impacts the reward circuits of the human brain of healthy individuals.. This …
The fall MDMA Therapy Training cohort is now underway and includes 520 trainees in a 100-hour online program, running through December 18. So far this year we’ve granted $900,000 in 231 Health Equity …
In September 2021, over 1,400 donors gave $535,588 in donations and pledges. We are so grateful to these supporters who advance our shared vision of creating safe and legal opportunities for the beneficial …
As leaders in psychedelic medicine, we embrace our obligation to provide patients a safe, supportive therapeutic context free from abuse and to cultivate ethical practices in psychedelic therapy. We are …
Letters in Nature Medicine address important challenges in evaluating psychedelic-assisted therapies The recent publication of results of the first Phase 3 clinical trial of MDMA-assisted therapy for posttraumatic …
All stakeholders at the Multidisciplinary Association for Psychedelic Studies (MAPS) and MAPS Public Benefit Corporation (MAPS PBC) are committed to providing quality and comprehensive training and supervision …
Psychedelic researcher Matthew W. Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine, recently received a grant from the National Institute on Drug Abuse …
